We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Opexa Therapeutics Announces TcelnaTM as New Brand Name for MS Therapy

Product News   May 22, 2012

 
Opexa Therapeutics Announces TcelnaTM as New Brand Name for MS Therapy
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

PerkinElmer Launches No-Wash Immunoassay for Neuroscience Disease and Therapeutics Research

Product News

PerkinElmer, Inc., today launched the life science industry’s first no-wash Ubiquitin phosphorylation at Serine 65 immunoassay that is aimed at helping scientists discover new therapeutic candidates earlier in the disease cycle.

READ MORE

Long-Acting Peptide Therapy for Heart Failure To Be Developed by AL-Protein and Bioscience

Product News

Antlia Bioscience, Inc., and XL-protein GmbH are pleased to announce a strategic slliance using XL-protein's proprietary PASylation® technology for plasma half-life extension to develop a novel, long-acting, peptide therapeutic treatment for chronic heart failure.

READ MORE

Biopharma Receives Positive EMA Opinion on Orphan Designation for Pancreatic Cancer Treatment

Product News

Prestige BioPharma Ltd. (hereinafter “Prestige BioPharma”) today announced that the European Medicines Agency (EMA) Orphan Drug Commission (COMP) has granted a positive opinion for an Orphan Drug Designation (ODD) status to its first-in-class anti-PAUF monoclonal antibody, PBP1510, for the treatment of pancreatic cancer.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE